OM - NASDAQ
Outset Medical, Inc.
$4.60
-6.3%Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
At a Glance
Live Snapshotom
Net Cash Provided by Financing Activities
Last Annual Value
55.50M
3-Year CAGR
-9%
5-Year CAGR
-32%
10-Year CAGR
-8%
Outset Medical, Inc. Competitors Analysis of Net Cash Provided by Financing Activities
| Company | Net Cash Provided by Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Outset Medical, Inc. NASDAQ:OM | 55.50M | 8.3% | -19.1% | N/A | |
 Caribou Biosciences, Inc. NASDAQ:CRBU | 4.82M | -68.5% | -59.3% | N/A | |
 CVRx, Inc. NASDAQ:CVRX | 10.52M | -24.0% | -37.7% | N/A | |
 Electromed, Inc. AMEX:ELMD | -11.88M | N/A | N/A | N/A | |
 SANUWAVE Health, Inc. NASDAQ:SNWV | -5.59M | N/A | N/A | N/A | |
 Owens & Minor, Inc. NYSE:OMI | -267.60M | N/A | N/A | N/A | |
 Quanterix Corporation NASDAQ:QTRX | -708.00K | N/A | N/A | N/A | |
 Inogen, Inc. NASDAQ:INGN | 24.18M | 193.1% | 10.0% | 12.1% | |
 Tenaya Therapeutics, Inc. NASDAQ:TNYA | 108.41M | 199.2% | -12.3% | N/A | |
 Viemed Healthcare, Inc. NASDAQ:VMD | -5.79M | N/A | N/A | N/A | |
 Perspective Therapeutics, Inc. AMEX:CATX | 10.30M | 135.9% | 183.8% | N/A |
Outset Medical, Inc. Fair Value Envelope
Related Guides
Continue your OM research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.